BrightWater Medical said today that it completed the sale of the organization to Merit Medical (NSDQ:MMSI), three months after Merit made its $50 million offer. In June, Merit valued the acquisition at $35 million upfront with a further $15 million in potential payments contingent upon CE Mark approval and meeting future sales targets. Temecula, Calif.-based BrightWater’s […]
BrightWater Medical
Merit puts $50m on the table for Brightwater
Merit Medical (NSDQ:MMSI) said this week that it plans to acquire Brightwater Medical in a deal valued at $50 million. Temecula, Calif.-based Brightwater Medical’s lead product, ConvertX, is a device designed to treat severe obstructions of the ureter. The company recently won FDA clearance for its ConvertX biliary stent system, according to Merit Medical. The deal […]
From Interventional Radiologist to Medtech CEO: Interview with Dr. Bob Smouse, Founder of BrightWater Medical
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! Dr. Bob Smouse has over 20 years of experience in interventional radiology, endovascular surgery and clinical research. In addition to acting as CEO and CMO of BrightWater […]
FDA clears BrightWater Medical’s ConvertX nephroureteral stent
Ureteral medical device company BrightWater Medical said today it won FDA 510(k) clearance for its ConvertX nephroureteral stent system designed for treating ureteral obstructions. The ConvertX System is designed as a single device intended to replace a series of devices and procedures used to treat severe obstructions of the ureter. Traditional interventions require an implanted nephrostomy catheter […]
BrightWater raises $5.2m in Series A to support ConvertX nephroureteral stent
Ureteral medical device company BrightWater Medical said today it closed a $5.2 million Series A round of financing to support its ConvertX Nephroureteral stent system designed for treating severe ureteral obstructions from development to regulatory filing. The ConvertX System is designed as a single device intended to replace a series of devices and procedures used […]